GWM
INCY icon

Geneos Wealth Management’s Incyte INCY Stock Holding History

Geneos Wealth Management’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-812
Closed -$55.3K – 2816
2025
Q2 		$55.3K Buy
812
+56
+7% +$3.55K ﹤0.01% 1514
2025
Q1 		$45.8K Buy
756
+588
+350% +$41K ﹤0.01% 1529
2024
Q4 		$11.6K Buy
168
+56
+50% +$3.99K ﹤0.01% 1992
2024
Q3 		$7.4K Buy
+112
New +$7.14K ﹤0.01% 1938
2020
Q1 		– Sell
-100
Closed -$8K – 2545
2019
Q4 		$8K Buy
+100
New +$8.54K ﹤0.01% 2052
2017
Q2 		– Sell
-9
Closed -$1K – 2104
2017
Q1 		$1K Sell
9
-16
-64% -$2.04K ﹤0.01% 1989
2016
Q4 		$2K Hold
25
– – ﹤0.01% 1866
2016
Q3 		$2K Buy
+25
New +$2.11K ﹤0.01% 1784

Other funds holding INCY

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Geneos Wealth Management's INCY Position: Q3 2025 in Review

Geneos Wealth Management sold out of Incyte (INCY) in Q3 2025, closing a stake of 812 shares — an estimated $55.3K sold.

Geneos Wealth Management first reported a position in INCY in Q3 2016 and held it in 8 quarters. The position peaked at $55.3K in Q2 2025. 713 funds tracked by Wall St. Rank hold INCY as of Q3 2025.

  • Geneos Wealth Management reported no remaining Incyte position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 812 Incyte shares in Q3 2025, an estimated $55.3K.
  • Geneos Wealth Management first reported a position in Incyte in Q3 2016 and held it in 8 quarters.
  • Geneos Wealth Management's Incyte position peaked at $55.3K in Q2 2025.
  • 713 funds tracked by Wall St. Rank held Incyte as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.